Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Innate Pharma S.A. - American Depositary Shares (NQ:IPHA)

1.510 -0.040 (-2.58%)
Streaming Delayed Price Updated: 11:12 AM EDT, Mar 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Innate Pharma S.A. - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Releases Its 2026 Financial Calendar
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma to Present at Jefferies Global Healthcare Conference
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma to Host Analyst and Investor Event on Lacutamab on October 28, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Reports First Half 2025 Business Update and Financial Results
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of September 1, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of August 1, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of July 3, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Highlights Preclinical Antitumor Activity of IPH6501 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma at the 2025 European Hematology Association (EHA) Congress
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences
From Innate Pharma SA
Via Business Wire
News headline image
Outcome of Innate Pharma’s 2025 Annual General Meeting
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Highlights Abstracts Selected for ASCO 2025 Annual Meeting
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Highlights ANKET® Abstracts Selected for the EHA 2025 Congress
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Reports First Quarter 2025 Business Update and Financial Results
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of May 5, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma announces conference call and webcast for Q1 2025 business update
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Files Its 2024 Universal Registration Document (Document d’enregistrement universel) and 2024 Annual Report on Form 20-F
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Highlights Preclinical Anti-Tumor Efficacy Data of Its Antibody Drug Conjugate IPH4502 at the AACR 2025 Annual Meeting
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of April 25, 2025
From Innate Pharma SA
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.